KIMBERLY CLARK CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data KIMBERLY CLARK CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	18,300	18,348	18,500	18,450	19,140	19,440	20,175	17,146	16,805	16,447
Cost of revenue	11,596	11,761	12,889	12,415	12,318	13,452	13,956	10,877	10,516	10,524
Gross profit	6,691	6,587	5,597	6,035	6,822	5,988	6,219	6,269	6,289	5,923
Research and development	326	309	317	284	276	269	292	303	328	326
Operating income	3,383	3,358	2,229	2,991	3,244	2,561	2,681	1,928	2,700	2,351
Interest expense	319	318	263	261	252	256	282	293	270	256
Interest income	11	10	10	11	8	6	14	66	48	24
Other non-operating income	-66	-59	-163	-91	-70	-86	-73	-96	-60	-67
Pre-tax income	3,009	2,991	1,813	2,650	2,930	2,225	2,340	2,021	2,927	2,052
Income tax	922	776	471	576	676	479	495	343	442	599
Income from continuing operations								1,459	2,159	1,621
Net income to minority interests	53	41	35	40	44	30	27	0	33	28
Net income	2,166	2,278	1,410	2,157	2,352	1,814	1,934	1,764	2,545	2,021
EBITDA	4,088	4,082	3,111	3,908	4,040	3,327	3,435	2,681	3,481	3,156
EPS, basic	6.03	6.44	4.05	6.28	6.90	5.38	5.73	5.22	7.58	6.09
EPS, diluted	5.99	6.40	4.03	6.24	6.87	5.35	5.72	5.21	7.55	6.07
Shares, basic (weighted)	359	354	348	344	341	337	337	338	336	332
Shares, diluted (weighted)	362	356	350	346	343	339	338	339	337	333
Dividend per share	3.68	3.88		4.12	4.28	4.56	4.64	4.72	4.88	5.04

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	923	616	539	442	303	270	427	1,093	1,010	688
Receivables	2,176	2,315	2,164	2,263	2,235	2,207	2,280	2,135	1,728	1,892
Inventory	1,679	1,790	1,813	1,790	1,903	2,239	2,269	1,955	1,452	1,475
Other current assets	337	490	525	562	733	849	753	520	694	535
Total current assets	5,115	5,211	5,041	5,057	5,174	5,565	5,729	5,703	5,580	5,310
Property, plant and equipment	7,169	7,436	7,159	7,450	8,042	8,097	7,885	7,913	6,284	6,775
Lease right-of-use assets				396	540			450	363	369
Goodwill	1,480	1,576	1,474	1,467	1,895	1,840	2,074	1,894	1,796	1,839
Intangible assets				29	832	810	851	197	80	77
Other non-current assets	581	695	620	1,012	1,280	1,235	1,193	1,140	984	1,062
Total assets	14,602	15,151	14,518	15,283	17,523	17,837	17,970	17,344	16,546	17,098
Accounts payable	2,609	2,834	3,190	3,055	3,336	3,840	3,813	3,653	3,264	3,388
Accrued liabilities	1,775	1,730	1,793	1,978	2,262	2,096	2,289	2,316	2,091	1,888
Short-term debt	1,133	953	1,208	1,534	486	433	844	567	564	694
Total current liabilities	5,846	5,858	6,536	6,919	6,443	6,749	7,334	6,930	7,004	7,125
Long-term debt	6,439	6,472	6,247	6,213	7,878	8,141	7,578	7,417	6,854	6,474
Lease liabilities				274				346	265	258
Other non-current liabilities	309	299	328	520	718	681	799	860	609	646
Total liabilities	14,485	14,269	14,564	15,089	16,654	17,100	17,270	16,276	15,571	15,468
Total debt	7,402	6,878	6,960	6,972	8,141	8,456	8,049	7,982	7,415	6,886
Paid-in capital	697	594	548	556	657	605	679	878	862	849
Retained earnings	5,831	5,769	5,947	6,686	7,567	7,858	8,201	8,368	9,257	9,611
Treasury stock	-3,629	-3,288	-3,956	-4,454	-4,899	-5,183	-5,137	-5,222	-5,986	-5,987
Other comprehensive income	-3,474	-2,919	-3,299	-3,294	-3,172	-3,239	-3,669	-3,582	-3,766	-3,444
Shareholders' equity	-102	882	-287	-33	626	514	547	915	840	1,502
Minority interests	219	253	241	227	243	223	153	153	135	128
Total equity	117	882	-46	194	869	737	700	1,068	975	1,630
Total liabilities and equity	14,602	15,151	14,518	15,283	17,523	17,837	17,970	17,344	16,546	17,098
Shares outstanding	357	351	345	341	339	337	338	337	332	332

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	2,219	2,319	1,445	2,197	2,396	1,844	1,961	1,764	2,578	2,049
Depreciation and amortization	705	724	882	917	796	766	754	753	781	805
Stock-based compensation	77	76	41	96	147	26	150	169	131	140
Deferred income tax	-15	-69	2	29	45	-70	-57	-322	-38	241
Change in receivables	-23	-44	33	-116	95	-37	-151	127	48	-58
Change in inventory	230	-33	-127	24	-96	-417	-76	290	10	70
Cash from operations	3,232	2,929	2,970	2,736	3,729	2,730	2,733	3,542	3,234	2,777
Capital expenditures	-771	-785	-877	-1,209	-1,217	-1,007	-876	-766	-721	-1,138
Acquisitions			0	-4	-1,083	0	-46	0	0
Sales and maturities of investments	28
Cash from investing	-732	-851	-902	-1,042	-2,305	-1,056	-785	-418	-100	-951
Debt issued	1,293	937	507	706	1,845	605	0	363	0	0
Debt repaid	-598	-1,481	-407	-707	-854	-269	-312	-475	-554	-550
Stock issued	107	121	62	228	217	65	94	97	136	40
Share buybacks	-739	-911	-800	-800	-700	-400	-100	-225	-1,000	-141
Dividends paid	-1,311	-1,359	-1,386	-1,408	-1,451	-1,516	-1,558	-1,588	-1,628	-1,660
Cash from financing	-2,185	-2,421	-2,115	-1,792	-1,567	-1,696	-1,760	-2,374	-3,166	-2,179
Exchange rate effect	-11	36	-30	1	4	-11	-31	-84	-40	33
Net change in cash	304	-307	-77	-97	-139	-33	157	666	-72	-320
Free cash flow	2,461	2,144	2,093	1,527	2,512	1,723	1,857	2,776	2,513	1,639
Interest paid	315	354	264	255	245	243	270	277	268	248
Income taxes paid	744	961	395	528	533	492	468	648	587	497

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $98.43 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	36.8%	Gross profit / revenue.
Operating margin	15.2%	Operating income / revenue.
EBITDA margin	19.5%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	13.5%	Pre-tax income / revenue.
Net margin	11.8%	Net income / revenue.
FCF margin	11.0%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	20.1%	Cash from operations / revenue.
Effective tax rate	32.7%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	111.7%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	10.5%	Net income / average total assets.
Return on invested capital (ROIC)	23.3%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	0.8%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	9.1%	Capital expenditures / revenue.
D&A / revenue	4.4%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-2.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-6.6%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-3.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-5.8%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-1.6%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-2.8%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-12.9%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-4.3%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-6.2%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-9.3%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-2.8%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-4.8%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-20.6%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	1.5%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-3.0%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-19.6%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	2.0%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-2.4%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-14.1%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	0.5%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-5.7%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-34.8%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-4.1%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-8.2%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	3.3%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	2.8%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	3.3%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	78.8%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	40.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	19.1%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	3.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-1.6%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-0.5%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.1%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.5%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.91x	Current assets / current liabilities.
Quick ratio	0.40x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.14x	(Cash + short-term investments) / current liabilities.
Debt / equity	3.70x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	34.9%	Total debt / total assets.
Liabilities / assets	89.9%	Total liabilities / total assets.
Net debt	$5.52B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	1.70x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	10.7x	Operating income / interest expense.
Working capital	-$634.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	10.3%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$154.0M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.89x	Revenue / average total assets.
Fixed asset turnover	2.39x	Revenue / average property, plant and equipment.
Inventory turnover	6.81x	Cost of revenue / average inventory.
Days inventory	54 days	365 x average inventory / cost of revenue.
Receivables turnover	8.92x	Revenue / average receivables.
Days sales outstanding	41 days	365 x average receivables / revenue.
Days payables	117 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	-23 days	Days inventory + days sales outstanding - days payables.
FCF conversion	93.1%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	45.4%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$5.88	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$49.75	Revenue / diluted weighted shares.
FCF per share	$5.46	Free cash flow / diluted weighted shares.
Operating cash flow per share	$10.00	Cash from operations / diluted weighted shares.
Book value per share	$5.26	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$0.46	Tangible book value / shares outstanding.
Cash per share	$2.87	(Cash + short-term investments) / shares outstanding.
Payout ratio	85.9%	Dividends paid / net income, when net income is positive.
Dividends / FCF	92.3%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	1.2%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$32.74B	Share price x shares outstanding.
Enterprise value	$38.25B	Market cap + total debt - cash - short-term investments.
P/E	16.7x	Market cap / net income. Only when net income is positive.
P/S	1.97x	Market cap / revenue.
P/B	18.7x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	18.0x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	9.82x	Market cap / cash from operations, when positive.
EV/Sales	2.31x	Enterprise value / revenue.
EV/EBIT	15.2x	Enterprise value / operating income, when both are positive.
EV/EBITDA	11.8x	Enterprise value / EBITDA, when both are positive.
EV/FCF	21.0x	Enterprise value / free cash flow, when both are positive.
FCF yield	5.6%	Free cash flow / market cap.
Earnings yield	6.0%	Net income / market cap (the inverse of P/E).
Dividend yield	5.1%	Dividends paid over the period / market cap.
Shareholder yield	5.2%	(Dividends paid + share buybacks) / market cap.
PEG	8.37x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was KIMBERLY CLARK CORP's revenue in fiscal 2025?

KIMBERLY CLARK CORP reported revenue of $16.45B for fiscal 2025, 2.1% lower than the year before.

Was KIMBERLY CLARK CORP profitable in fiscal 2025?

Yes. Net income was $2.02B, a net margin of 12.3%.

How much free cash flow did KIMBERLY CLARK CORP generate in fiscal 2025?

Cash from operations of $2.78B minus capital expenditures of $1.14B left free cash flow of $1.64B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to KIMBERLY CLARK CORP